Showing results (981-990 of 2,357) with videos related to
Sort By:
Pageof 236
Clinical Neuropharmacology|September 19, 2013
Effectiveness and tolerability of switching to aripiprazole from risperidone in subjects with autism spectrum disorders: a prospective open-label studyMakoto Ishitobi, Hirotaka Kosaka, Tetsuya Takahashi, et al.Clinical Neuropharmacology|September 19, 2013
Impulse control disorder in a patient on long-term treatment with bromocriptine for a macroprolactinomaSravan Kumar Thondam, Sundus Alusi, Kieran O'Driscoll, et al.Clinical Neuropharmacology|September 19, 2013
Repeated erythromycin/codeine-induced psychotic maniaMirko Manchia, Martin Alda, Cynthia V CalkinClinical Neuropharmacology|January 13, 2016
Parkinsonism in Patients With Chronic Hepatitis C Treated With Interferons: Case Reports and Review of the LiteratureKirk J Wangensteen, Edward L Krawitt, Robert W Hamill, et al.Clinical Neuropharmacology|January 13, 2016
Spontaneous Remission of Ketamine Withdrawal-Related DepressionPo-Chun Lin, Hsien-Yuan Lane, Chieh-Hsin LinClinical Neuropharmacology|January 13, 2016
Effect of Primidone on Dentate Nucleus γ-Aminobutyric Acid Concentration in Patients With Essential TremorElan D Louis, Nora Hernandez, Jonathan P Dyke, et al.Clinical Neuropharmacology|January 13, 2016
Use of Ketamine in Barbiturate Coma for Status EpilepticusKaitlin Ann McGinn, Laura Bishop, Aarti SarwalClinical Neuropharmacology|November 5, 2015
Safety, Tolerability, and Pharmacokinetics of Fosphenytoin Loading in Patients With Subarachnoid HemorrhageDong Wook Kim, Tae-Eun Kim, Misuk Ji, et al.Clinical Neuropharmacology|November 5, 2015
A Randomized Controlled Trial of Subcutaneous Apomorphine for Parkinson Disease: A Repeat Dose and Pharmacokinetic StudyMasahiro Nomoto, Shin-ichiro Kubo, Masahiro Nagai, et al.Clinical Neuropharmacology|January 29, 2016
Clinical/Therapeutic Approaches for Cannabinoid Ligands in Central and Peripheral Nervous System Diseases: Mini ReviewKatarzyna Fijał, Małgorzata FilipPageof 236